2007, 1. ed., Diálogo abierto. Ensayo, ISBN 9789706333377, 88
Book
2001, 1a. ed., FilologÃa, ISBN 8477565171, Volume 9., 376
Book
Bulletin of Hispanic Studies, ISSN 1475-3839, 05/2017, Volume 94, Issue 5, pp. 529 - 543
The aim of this paper is to demonstrate that ‘Chac Mool’ (1954) by Carlos Fuentes and ‘Coatlicue’ (2003) by Elena Poniatowska are short stories that utilize...
Mexican literature | "Chac Mool" | "Coatlicue" | Poniatowska, Elena | national identity | Aztec Indian culture | 1900-1999 | short story | Fuentes, Carlos | Análisis del discurso | Literatura mexicana | Uto Aztecan languages | Literary motif | CosmologÃa | Identidad nacional | Cultura mexicana | 21st century | 20th century | MitologÃa | Dialogue | Short stories | CrÃtica literaria | Short story | Aztec civilization | Poética | National identity | Historia hispanoamericana | Mexican culture | Narrativa breve | Poetics | Diálogo | Literary criticism | Latin American history | Mythology | Cosmology | Siglo XXI | Discourse analysis | Siglo XX | Motivo literario
Mexican literature | "Chac Mool" | "Coatlicue" | Poniatowska, Elena | national identity | Aztec Indian culture | 1900-1999 | short story | Fuentes, Carlos | Análisis del discurso | Literatura mexicana | Uto Aztecan languages | Literary motif | CosmologÃa | Identidad nacional | Cultura mexicana | 21st century | 20th century | MitologÃa | Dialogue | Short stories | CrÃtica literaria | Short story | Aztec civilization | Poética | National identity | Historia hispanoamericana | Mexican culture | Narrativa breve | Poetics | Diálogo | Literary criticism | Latin American history | Mythology | Cosmology | Siglo XXI | Discourse analysis | Siglo XX | Motivo literario
Journal Article
Bulletin of Hispanic Studies, ISSN 1475-3839, 2017, Volume 94, Issue 5, p. 529
Journal Article
Revista Mexicana de Biodiversidad, ISSN 1870-3453, 09/2019, Volume 90, Issue 1
Journal Article
Journal of Carbohydrate Chemistry, ISSN 0732-8303, 03/2018, Volume 37, Issue 3, pp. 164 - 164
Journal Article
Advances in Intelligent Systems and Computing, ISSN 2194-5357, 2018, Volume 721, pp. 242 - 251
Conference Proceeding
BULLETIN OF HISPANIC STUDIES, ISSN 1475-3839, 2017, Volume 94, Issue 5, pp. 529 - 543
The aim of this paper is to demonstrate that 'Chac Mool' (1954) by Carlos Fuentes and 'Coatlicue' (2003) by Elena Poniatowska are short stories that utilize...
LITERATURE, ROMANCE
LITERATURE, ROMANCE
Journal Article
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk...
MEDICINE, GENERAL & INTERNAL | BASE-LINE | EVENTS | EFFICACY | SAFETY | PEPTIDE-1 RECEPTOR AGONISTS | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Elderly
MEDICINE, GENERAL & INTERNAL | BASE-LINE | EVENTS | EFFICACY | SAFETY | PEPTIDE-1 RECEPTOR AGONISTS | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Elderly
Journal Article
MEDISAN, ISSN 1029-3019, 06/2014, Volume 18, Issue 6, pp. 884 - 887
Se exaltan las cualidades humanas, la actitud profesional y la condición revolucionaria de la enfermera santiaguera Clara Elena Pérez Frómeta, quien se destacó...
MEDICINE, GENERAL & INTERNAL
MEDICINE, GENERAL & INTERNAL
Journal Article
Medisan, ISSN 1029-3019, 06/2014, Volume 18, Issue 6, pp. 884 - 887
Se exaltan las cualidades humanas, la actitud profesional y la condición revolucionaria de la enfermera santiaguera Clara Elena Pérez Frómeta, quien se destacó...
personalidad médica | profesionalidad | enfermera
personalidad médica | profesionalidad | enfermera
Journal Article
2002, Contributions in women's studies, ISBN 031331120X, Volume no. 190, xvii, 134
Book
1994, Colección Lago de Maracaibo, ISBN 9802324566, 191
Book
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the...
MEDICINE, GENERAL & INTERNAL | BASE-LINE | LIRAGLUTIDE | INCRETIN | CARDIOVASCULAR OUTCOMES | DISEASE | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment
MEDICINE, GENERAL & INTERNAL | BASE-LINE | LIRAGLUTIDE | INCRETIN | CARDIOVASCULAR OUTCOMES | DISEASE | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment
Journal Article